Clinician and Patient Involvement Group (CAPIG)

CAPIG is part of the All Wales Medicines Strategy Group (AWMSG) health technology appraisal (HTA) process for new orphan/ultra-orphan medicines and medicines used to treat a rare disease. The aim of CAPIG is to identify and discuss in more detail any additional benefits of the medicine from both a clinician and patient perspective. The additional information gathered for CAPIG (the CAPIG report) will be presented to AWMSG and this will help AWMSG make a decision that takes greater account of the patient and clinician perspective.

All Glossary Entries